Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose aspirin in women with polycystic ovary syndrome
ChiCTR-TRC-14005116Phase 4Recruiting
- Sponsor
- Renji Hospital
- Start
- Jan 1990
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of aspirin and drospirenone in polycystic ovary syndrome (PCOS) (3 arms), sponsored by Renji Hospital. Primary endpoints: fasting blood glucose, fasting insulin and 4 more. Started Jan 1990; status: recruiting.
02
Drugs
aspirindrospirenone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR-TRC-14005116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14005116.